The Complex Landscape of PTEN mRNA Regulation

Related Experiment Video

Updated: Jan 1, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.7K

Erin Sellars1, Martino Gabra1, Leonardo Salmena1,2

  • 1Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

Cold Spring Harbor Perspectives in Medicine
|December 25, 2019
PubMed

Insights

Small reductions in the tumor suppressor Phosphatase and tensin homolog (PTEN) can promote cancer. This study details the complex regulation of PTEN mRNA stability and expression in PTEN loss-associated cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Phosphatase and tensin homolog (PTEN) is a critical tumor suppressor involved in various cancer types.
  • Reduced PTEN protein levels are increasingly recognized as a driver of cancer development and progression.
  • PTEN expression is meticulously regulated through multiple layers, from epigenetic modifications to protein stability.

Purpose of the Study:

  • To provide a comprehensive overview of the regulatory mechanisms governing PTEN messenger RNA (mRNA) expression.
  • To elucidate how alternative splicing and polyadenylation influence PTEN mRNA stability and levels.
  • To contextualize PTEN mRNA regulation within the landscape of PTEN loss-associated cancers.

Main Methods:

  • Literature review and synthesis of current research on PTEN regulation.
  • Analysis of epigenetic, transcriptional, and post-transcriptional control mechanisms.
  • Focus on RNA-level regulation including microRNAs, noncoding RNAs, and RNA-binding proteins.

Main Results:

  • PTEN mRNA is subject to intricate regulation by various non-coding RNAs and RNA-binding proteins.
  • Alternative splicing and variable polyadenylation significantly impact PTEN mRNA stability and expression levels.
  • These regulatory processes are crucial in the context of cancers with PTEN loss.

Conclusions:

  • The complex regulatory network of PTEN mRNA is essential for maintaining its tumor suppressor function.
  • Dysregulation of PTEN mRNA stability and expression contributes to the pathogenesis of PTEN loss-associated cancers.
  • Understanding these regulatory mechanisms offers potential therapeutic targets for cancer treatment.

More Related Videos

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.6K
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

11.5K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K